STEPHANIE ONDATJE: Open Payments
NPI 1649755919 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 11 payments from 8 companies in 2025. Trend: 2023 $172 · 2024 $198 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Travere Therapeutics, Inc. | 2 | $13 |
Products named: JYNARQUE, JARDIANCE, Fabhalta, Venxxiva, TAVNEOS, Kerendia, FARXIGA.
Industry payments across MO — which companies pay providers there.
